Koers ContraVir Pharmaceuticals Inc OTC Bulletin Board
Aandelen
US21234W1036
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
|
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 14,05 mln. 12,88 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -42 mln. -38,5 mln. | Nettowinst (verlies) 2023 | -48 mln. -44 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 51,14 mln. 46,87 mln. | Nettoliquiditeiten 2023 | 14,58 mln. 13,36 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-0,5
x | K/w-verhouding 2023 |
-0,26
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 94,28% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Cavan
CEO | Chief Executive Officer | 65 | 01-01-16 |
Daren Ure
CTO | Chief Tech/Sci/R&D Officer | - | 03-10-19 |
Stephen Kilmer
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Brancaccio
CHM | Chairman | 76 | 15-05-13 |
Timothy Block
BRD | Director/Board Member | 69 | 26-11-13 |
Kaouthar Lbiati
BRD | Director/Board Member | 45 | 27-06-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,17% | 126 mld. | |
+24,67% | 118 mld. | |
+24,13% | 27,87 mld. | |
-17,74% | 20,95 mld. | |
-15,03% | 16,92 mld. | |
-15,21% | 16,18 mld. | |
+11,91% | 14,84 mld. | |
-47,10% | 14,79 mld. | |
+54,50% | 14,08 mld. |
- Beurs
- Aandelen
- Koers HEPA
- Koers